Publications by authors named "Jonathan D Sorah"

Claim this Profile
A
Anatomic Location Predicts Response Rates: Real World Outcomes With Over 1100 Cycles of Talimogene Laherparepvec Description: A Retrospective Review of a Prospectively Maintained Database.
Kristen E Dougherty, Gray B Peery, Chris B Agala, Veronica P Pham, Morgan E Gwynn, Jonathan D Sorah

Ann Surg· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II single-arm study of palbociclib and cetuximab in anti-EGFR naïve patients with KRAS/NRAS/BRAF wild-type, metastatic colorectal cancer.
Jonathan D Sorah, Dominic T Moore, Matthew J Reilley, Mohamed E Salem, Tammy Triglianos

Oncologist· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Role of Patient Preferences in Hepatocellular Carcinoma Treatment Decisions: A Qualitative Study.
Andrew M Moon, Daniel Richardson, Gabriel V Lupu, Donna M Evon, Hanna K Sanoff, Jonathan D Sorah

MDM Policy Pract· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal patient-reported outcomes on genotype-guided irinotecan dosing: feasibility and clinical relevance.
Jonathan D Sorah, Allison M Deal, Sophia I Stein, Mattias Jonsson, Federico Innocenti

Oncologist· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancer.
Hanna K Sanoff, Allison M Deal, Jai Patel, Jonathan D Sorah, Jacquelyne Gaddy

Oncologist· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Histological Response to Talimogene Laherparepvec Therapy in Advanced Melanoma: Impact on Overall Survival.
Gabriel O Ologun, C Paige Jones, Kelsey R Landrum, P Veronica Pham, Sherin Ismail, Jonathan D Sorah

J Am Coll Surg· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seeking Racial Equity in Hematology and Oncology: a Fellow-Led Educational Series to Promote Reflection and Action.
Jacob N Stein, Jacquelyne J Gaddy, Jonathan D Sorah, Melissa Wooten, Keisha Gibson

J Cancer Educ· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: Improving Fellow Performance of the Pharmacology Section of the American Society of Clinical Oncology In-Training Exam.
Jonathan D Sorah, Sean Clark-Garvey, Frances A Collichio

J Cancer Educ· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Single-Arm Study of Palbociclib and Cetuximab Rechallenge in Patients with KRAS/NRAS/BRAF Wild-Type Colorectal Cancer.
Jonathan D Sorah, Dominic T Moore, Matthew J Reilley, Mohamed E Salem, Tammy Triglianos

Oncologist· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and Prediction of Immune Checkpoint Inhibitor-related Nephrotoxicity.
Jonathan D Sorah, Tracy L Rose, Roshni Radhakrishna, Vimal K Derebail, Matthew I Milowsky

J Immunother· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis